If you can see this message, your browser does not support canvas and needs an update. Sorry. :(
Tuesday, September 25, 2018 
Market Status: CLOSE
About us and Governance Investor Relations Contact
Advanced search

Market News


ZENTIVA S.A. - SCD

Press release - public offer

Release Date: 2/15/2018 11:03:43 AM

IRIS Code: 14C12

 

Zentiva N.V. is initiating a public offering for the acquisition of Zentiva S.A. (former S.C. Sicomed S.A. – Medicine Plant) shares

 

 

Bucharest, February 15th, 2018 – Zentiva N.V. is initiating, between 20.02.2018 – 05.04.2018, a public offering for the acquisition of all the shares outstanding of the company Zentiva S.A. (former S.C. Sicomed S.A. – Medicine Plant) which are not held by it and by the persons acting in concert, namely a number of 76.377.607 shares, accounting for 18.32% of the company’s share capital.

 

BRD – Groupe Societe Generale S.A. will act as agent in the stock acquisition public offering.

 

The acquisition price (price of the offering) for each Zentiva S.A. share is of 3.5 Ron/share.

 

The persons interested in obtaining additional information can call at 021.302.61.55, the dedicated Public Offering Call Center, or at 021.301.41.52, 021.301.68.73, 021.301.49.81, 021.301.41.55. The document and the announcement of the offering, and also the ASF decision are available on the institutional websites of Zentiva S.A. (www.zentiva.ro), Bucharest Stock Exchange (www.bvb.ro) and BRD - Groupe Societe Generale S.A. (www.brd.ro).

 

The offering document was approved by the Financial Supervisory Authority (ASF) by decision no. 224 of 14.02.2018.

 

 

Details about the Public Offering

Offeror – Zentiva N.V., part of Sanofi Group;

Issuer – Zentiva S.A.;

Agent - BRD – Groupe Societe Generale S.A.

 

Where to obtain the statement of account?

       BRD Office in 1-7 Ion Mihalache Blvd., Bucharest;

       BRD Unirii Branch Bank, 2 Mircea Voda Blvd., Bucharest

       One of the agents authorized by ASF. Please find the full list, organized by city, by accessing http://www.bvb.ro/Intermediaries/ListOfIntermediaries/GeneralIndex

       Depozitarul Central S.A. (Central Depository) - Bucharest, 34-36 Carol I Blvd., 3rd floor, district 2, phone no. 021.408.58.00

 

Where to subscribe?

       BRD Office in 1-7 Ion Mihalache Blvd., Bucharest;

       BRD Unirii Branch Bank, 2 Mircea Voda Blvd., Bucharest  

       The office of any authorized agent. The full list, organized by city, is available on http://www.bvb.ro/Intermediaries/ListOfIntermediaries/GeneralIndex

Working hours: throughout the deployment of the offering, during working days between 09.00 and 17.00, except for the closing date of the offering, when the work schedule is between 09.00 and 13.00.

 

Before subscribing, it is recommended to read the offering document available on the website: www.zentiva.ro,  www.brd.ro or www.bvb.ro.

 

 

The approval stamp affixed on the offering document does not account for a guarantee or any form of appreciation by ASF concerning the opportunity, advantages or disadvantages, profit or risks that may arise following the transactions to be concluded by accepting the public offering subject to the decision of approval. The decision of approval only certifies the conformity of the offering document with the legal requirements and the rules adopted for the enforcement thereof. This offering is solely addressed to Zentiva S.A. shareholders, as per the applicable regulations. Approved by the Financial Supervisory Authority by decision no. 224 of 14.02.2018.

 

About Zentiva, a Sanofi company

Zentiva is part of Sanofi Group since March 2009.

The company's product portfolio covers a wide range of therapeutic areas, with focus on: cardiovascular, inflammatory, pain, infection and CNS disorders, as well as on gastrointestinal and urological disorders.

           

 

Media contacts:

Camelia Nitu, Communication Head Sanofi Romania & Moldova

0723.353.520, camelia.nitu@sanofi.com

Irina Patru-Florea, Account Manager Free Communication

0752.111.725, irina.patru@freecomm.ro

 

 



 Print

Information provided by IRIS, the news platform of the Bucharest Stock Exchange.

______________________

Bucharest Stock Exchange ("BVB") is not responsible for the content of this News item. Issuers whose financial instruments are traded on markets operated by BVB are required to report in accordance with current legal and regulatory provisions. BVB publishes these Reports as market administrator, appointed by ASF. When, for investors’ information, Reports are published, either signed by different persons, or with conflicting information, legal liability lies fully with the signatories. BVB disclaims any obligation or responsibility towards issuers or third parties, regarding the reality, completeness and accuracy of information provided by them and distributed by BVB. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.


©2016 Bucharest Stock Exchange. All rights reserved